IRCT20210201050197N1尚未招募未知
Single-dose bioequivalence studies of Duloxetine (60 mg) in healthy volunteers
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Healthy volunteer
- •Age: 18-50 year
排除标准
- •History of liver, kidney and cardiovascular diseases that can affect drug clearance from body
- •History of taking any medication in the last two weeks
- •Creatinine above 2
研究者
相似试验
已完成
不适用
Bioequivalence study of Duloxetine 30 mg enteric coated capsule in 24 healthy male under fasting conditionsBioequivalence investigation of the generic Actover.Duloxetine 30 mg enteric coated capsule with brand Cymbalta® Eli Lilly capsule..IRCT20180620040164N23ACtover Pharmaceutical Co.26
已完成
不适用
Bioequivalence study of Duloxetine 30mg capsuleThis study is performed on healthy volunteers..IRCT20200623047902N16Sanamed pharma company24
尚未招募
不适用
Bioequivalence evaluation of Duloxetine Capsule 60 mg manufactured by Behin Tamin Rosamed company-.Major depressive disorder, recurrent, mildF33.0IRCT20200625047913N5Hezareh Sevom Futuristic Pharmacist24
招募中
不适用
In-vivo Bioequivalence Test of Dapoxetine tablet 30 mg Mofid Pharma with brand drug (PRILIGY® 30 mg Tab, Menarini, Italy)IRCT20200105046010N64Teb Mofid Nikan Pharmaceutical Co.24
未知
4 期
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic PaiDiabetic Peripheral Neuropathic PainJPRN-jRCT1080222824Shionogi & Co., Ltd.